CD274 and cancer: The results of our analysis showed that ASB16-AS1 and PD-L1 inhibitor was significantly related in a variety of cancer types, and further analyzed the evaluation of ASB16-AS1 and potential immune effect evaluation molecules, such as TMB and MSI.